Zentiva, a leading European generics pharmaceutical company, Advent and GTCR – two leading global private equity investors – today announce the sale of Zentiva by Advent to GTCR.
At Zentiva, we provide health and wellbeing for all generations
News from Zentiva
-
September 11, 2025 / News
-
July 17, 2025 / News
We are delighted to announce that Zentiva Ankleshwar has been certified as a Great Place to Work® for the second consecutive year. This prestigious recognition is not merely a badge of honor; it is a testament to the collective voice of our dedicated employees.
-
April 9, 2025 / News
For the fourth consecutive year, Zentiva is publishing its Sustainability Report, highlighting the key achievements delivered in 2024.
-
June 21, 2024 / News
Zentiva is proud to be certified first ever by Great Place to Work organization in India, covering the period from June 2024 to June 2025.
-
June 7, 2024 / News
Steffen Saltofte, CEO of Zentiva, told TIME that whatever the future holds, Zentiva has been an active leader in the pharmaceutical sector for 500 years, and it will carry on for at least the next 500.
-
April 30, 2024 / News
Zentiva is a leading manufacturer and supplier of high-quality and affordable medicines to more than 100 million people in Europe and beyond.
-
September 11, 2025 / News
Zentiva, a leading European generics pharmaceutical company, Advent and GTCR – two leading global private equity investors – today announce the sale of Zentiva by Advent to GTCR.
-
July 17, 2025 / News
We are delighted to announce that Zentiva Ankleshwar has been certified as a Great Place to Work® for the second consecutive year. This prestigious recognition is not merely a badge of honor; it is a testament to the collective voice of our dedicated employees.
-
April 9, 2025 / News
For the fourth consecutive year, Zentiva is publishing its Sustainability Report, highlighting the key achievements delivered in 2024.
-
June 21, 2024 / News
Zentiva is proud to be certified first ever by Great Place to Work organization in India, covering the period from June 2024 to June 2025.
-
June 7, 2024 / News
Steffen Saltofte, CEO of Zentiva, told TIME that whatever the future holds, Zentiva has been an active leader in the pharmaceutical sector for 500 years, and it will carry on for at least the next 500.
-
April 30, 2024 / News
Zentiva is a leading manufacturer and supplier of high-quality and affordable medicines to more than 100 million people in Europe and beyond.
-
December 29, 2018 / Featured
Zentiva and PHOENIX joined forces this week for an inaugural Annual Partnership meeting in Prague to kick off a strategic partnership between the two healthcare companies in Europe.